EZH2 and T-cell acute lymphoblastic leukemia: However, EZH2 can also act as a tumor suppressor, with loss-of-function mutations identified in a subset of myelodisplastic syndromes, myeloproliferative neoplasms and T cell acute lymphoblastic leukemias.